Feb 16, 2021
Dr. Nick West, Chief Medical Officer and DVP, Global Medical Affairs, Vascular Division, Abbott reveals the advances over traditional angiograms that Abbott is bringing to the market that change the ability to see inside blood vessels. Using the Optical Coherence Tomography (OCT) to examine coronary arteries,...
Feb 16, 2021
Dr. Nick West, Chief Medical Officer and DVP, Global Medical Affairs, Vascular Division, Abbott reveals the advances over traditional angiograms that Abbott is bringing to the market that change the ability to see inside blood vessels. Using the Optical Coherence Tomography (OCT) to examine coronary arteries,...
Oct 5, 2020
Craig Fraser, CEO and President, Windtree Therapeutics talks about acute heart failure, the number one reason for hospitalization in people over 65 and the fact that there has been little innovation in trying to improve cardiac function. Developing a novel dual action drug called istaroxime, Windtree is addressing both...
Oct 5, 2020
Craig Fraser, CEO and President, Windtree Therapeutics talks about acute heart failure, the number one reason for hospitalization in people over 65 and the fact that there has been little innovation in trying to improve cardiac function. Developing a novel dual action drug called istaroxime, Windtree is addressing both...
Sep 23, 2020
Fred Colen, Chief Executive Officer, Neovasc sheds light on the four classes of angina and how the quality of life deteriorates for patients suffering from symptoms. Looking for the fundamental reason for the chronic condition of refractory angina has led Neovasc to address the small blood vessels inside the myocardium,...